SCHEMBL6618609

SCHEMBL6618609

NC(=O)C1OCc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.42
ALDH1A1 P00352 4/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 2/20 0.41
NISCH Q9Y2I1 1/20 0.41
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
F2 P00734 2/20 0.38
KMT2A Q03164 2/20 0.37
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
CYP2D6 P10635 2/20 0.35
SLC6A2 P23975 2/20 0.35
LMNA P02545 1/20 0.35
SLC6A4 P31645 1/20 0.35
HTR2A P28223 1/20 0.35
ANPEP P15144 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28327093 0.85 RAB9A (0.40) ALDH1A1RAB9ANISCHTSHRMAPK1
SCHEMBL16244206 0.84 RAB9A (0.57) ATMALDH1A1GAARAB9ATSHR
SCHEMBL3639787 0.83 TSHR (0.41) ALDH1A1GAARAB9ANISCHTSHR
SCHEMBL10518091 0.80 RAB9A (0.38) ALDH1A1GAARAB9ANISCHTSHR
SCHEMBL28002393 0.79 RAB9A (0.37) ALDH1A1RAB9ANISCHTSHRMAPK1
SCHEMBL1503176 0.77 FDPS (0.36) ALDH1A1TSHRKMT2A
SCHEMBL3855349 0.76
SCHEMBL14783854 0.76 ALDH1A1 (0.38) ATMALDH1A1GAARAB9ANISCH
SCHEMBL28440436 0.75 FABP7 (0.39) RAB9AF2KMT2ACYP2D6SLC6A2
SCHEMBL17231948 0.74 TSHR (0.44) ALDH1A1TSHRKMT2ACYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124810-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2001-08-22 EP claimed
WO-2000026202-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-05-11 WO claimed
CN-101928269-A The crystalline alkali of escitalopram and the oral cavity dispersible tablet that comprises escitalopram alkali LUNDBECK & CO AS H 2010-12-29 CN disclosed
CN-101189220-A Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base LUNDBECK & CO AS H (DK) 2008-05-28 CN disclosed
EP-1458703-A1 ISOCHROMAN COMPOUNDS FOR TREATMENT OF CNS DISORDERS ELI LILLY AND COMPANY (US) 2004-09-22 EP disclosed
EP-1345930-A2 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2003053948-A1 ISOCHROMAN COMPOUNDS FOR TREATMENT OF CNS DISORDERS ELI LILLY AND COMPANY (US) 2003-07-03 WO disclosed
EP-1296970-A1 METHOD FOR THE PREPARATION OF CITALOPRAM H. Lundbeck A/S (DK) 2003-04-02 EP disclosed
WO-2002050067-A2 PHARMACEUTICAL HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed
WO-2001085712-A1 METHOD FOR THE PREPARATION OF CITALOPRAM H. LUNDBECK A/S (DK) 2001-11-15 WO disclosed
EP-1124810-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2001-08-22 EP disclosed
WO-2000026202-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-05-11 WO disclosed